Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva makes unsolicited $40B bid for rival Mylan in effort to spawn generics titan
Teva makes unsolicited $40B bid for rival Mylan in effort to spawn generics titan
Teva makes unsolicited $40B bid for rival Mylan in effort to spawn generics titan
Submitted by
admin
on April 21, 2015 - 12:16pm
Source:
BioPharma Dive
News Tags:
Teva Pharmaceutical
Mylan
M&A
Headline:
Teva makes unsolicited $40B bid for rival Mylan in effort to spawn generics titan
Do Not Allow Advertisers to Use My Personal information
